InsiderClue
Insiders · Profile

Peterson Amy C.

EVP Prod Dev & Med Aff & CMO at EXELIXIS · EVP, Chief Development Officer at CytomX Therapeutics · CMO, Immuno-oncology at BeOne Medicines. Filing since 13 Nov 2017. CIK 0001682735

EXEL EXELIXIS, INC. EVP Prod Dev & Med Aff & CMO · 1 trade CTMX CytomX Therapeutics, Inc. EVP, Chief Development Officer · 2 trades ONC BeOne Medicines Ltd. CMO, Immuno-oncology · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
EXEL EXELIXIS, INC.
16 May 2025
EVP Prod Dev & Med Aff & CMO
Sold at will
72,776
$3.31M
13.5%
CTMX CytomX Therapeutics, Inc.
16 Mar 2023
EVP, Chief Development Officer
Sold at will
4,257
$8.42K
6.8%
CTMX CytomX Therapeutics, Inc.
20 Jul 2022
EVP, Chief Development Officer
Sold, plan not stated
7,463
$10.61K
10.6%
ONC BeOne Medicines Ltd.
18 Dec 2018
CMO, Immuno-oncology
Sold, plan not stated
10,141
$1.36M
100%
ONC BeOne Medicines Ltd.
17 Dec 2018
CMO, Immuno-oncology
Sold, plan not stated
9,859
$1.32M
100%
ONC BeOne Medicines Ltd.
12 Nov 2018
CMO, Immuno-oncology
Sold, plan not stated
12,067
$1.36M
100%
ONC BeOne Medicines Ltd.
9 Nov 2018
CMO, Immuno-oncology
Sold, plan not stated
13,222
$1.59M
100%
ONC BeOne Medicines Ltd.
8 Nov 2018
CMO, Immuno-oncology
Sold, plan not stated
14,711
$1.85M
100%
ONC BeOne Medicines Ltd.
23 Aug 2018
CMO, Immuno-oncology
Sold, plan not stated
5,769
$975.67K
100%
ONC BeOne Medicines Ltd.
13 Nov 2017
CMO, Immuno-oncology
Sold, plan not stated
3,601
$298.75K
100%
10 decisions on file.